Ledyard National Bank’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-4,500
Closed -$41K 757
2016
Q4
$41K Sell
4,500
-850
-16% -$7.91K 0.01% 331
2016
Q3
$50K Sell
5,350
-179,450
-97% -$1.71M 0.01% 318
2016
Q2
$1.89M Sell
184,800
-23,550
-11% -$216K 0.34% 88
2016
Q1
$1.88M Sell
208,350
-15,300
-7% -$137K 0.33% 91
2015
Q4
$2.07M Sell
223,650
-93,525
-29% -$1.02M 0.37% 85
2015
Q3
$4.05M Sell
317,175
-13,925
-4% -$173K 0.78% 47
2015
Q2
$3.66M Buy
+331,100
New +$3.66M 0.64% 59

Other funds holding RDY

Ledyard National Bank's RDY Position: Q1 2017 in Review

Ledyard National Bank sold out of Dr. Reddy's Laboratories (RDY) in Q1 2017, closing a stake of 4,500 shares — an estimated $41K sold.

Ledyard National Bank first reported a position in RDY in Q2 2015 and held it in 7 quarters. The position peaked at $4.05M in Q3 2015. 134 funds tracked by Wall St. Rank hold RDY as of Q1 2017.

  • Ledyard National Bank reported no remaining Dr. Reddy's Laboratories position as of Q1 2017 after selling out during the quarter.
  • Ledyard National Bank sold 4,500 Dr. Reddy's Laboratories shares in Q1 2017, an estimated $41K.
  • Ledyard National Bank first reported a position in Dr. Reddy's Laboratories in Q2 2015 and held it in 7 quarters.
  • Ledyard National Bank's Dr. Reddy's Laboratories position peaked at $4.05M in Q3 2015.
  • 134 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2017.

Based on Ledyard National Bank's 13F filing for Q1 2017, filed 19 Apr 2017.